1,2,4-triazole | 444 |
32 full factorial design | 132 |
4-Hydroxynonenal | 54 |
4-thiazolidinone | 1 |
Abrus precatorius | 88 |
Acute toxicity | 478 |
Akt activity | 119 |
Alchemilla persica | 261 |
Aldose reductase | 206 |
Aldose reductase inhibition | 1 |
Alloxan | 261 |
Alzheimer’s disease | 413 |
ANN | 211 |
Anti-angiogenesis | 303 |
Anti-cancer | 273 |
Anti-inflammatory | 175, 273 |
Anti-inflammatory activity | 240 |
Anticancer and antimicrobial activities | 413 |
Antidiabetic activity | 261, 335 |
Antimicrobial | 69 |
Antimicrobial activity | 240 |
Antimycobacterial | 196 |
Antimycobacterial activity | 444 |
Antioxidant | 155, 175, 234 |
Antioxidant activity | 375, 413 |
Aphrodisiacs | 317 |
Aphthous ulcers | 348 |
Apiaceae | 191, 317 |
Apoptosis | 101, 119, 282 |
Artemisia campestris | 234 |
Ascorbic acid | 462 |
Atorvastatin/fenofibrate combined dosage form | 62 |
Azithromycin dihydrate | 437 |
Bibliometric | 115 |
Bioautography | 69 |
Bioavailability | 265 |
Biochemical indices | 88 |
Biofilm | 456 |
Biorelevant/discriminative dissolution method | 62 |
Blood boron concentration | 96 |
Boron exposure | 96 |
Box–Behnken design | 326 |
Buffer solution | 252 |
Calendula officinalis | 292 |
Cancer | 101, 119 |
Cancer cell lines | 273 |
Cancer cells | 387 |
Centaurea solstitialis | 273 |
Central composite design | 20 |
Ceragenin | 456 |
Characterization of microspheres | 20 |
Chemometric analysis | 141 |
Chemotaxonomy | 191 |
Chick chorioallantoic membrane assay | 303 |
Chlorogenic acid | 234 |
Chromatographic fingerprinting | 76 |
Cigarette | 371 |
CLP | 428 |
Cnidoscolus aconitifolius | 387 |
Coating | 340 |
Cochlea | 169 |
Community pharmacy | 14 |
Controlled drug release | 493 |
Correlation | 292 |
Crosslinking agent | 252 |
Curcumin | 169, 366 |
Cyclooxygenase-2 | 54 |
Cytotoxicity | 37, 387, 488 |
Dapagliflozin | 227 |
Daucane sesquiterpene esters | 488 |
Derivative spectrophotometry/quantification simultaneously | 62 |
Detoxification properties | 155 |
Devitrification | 211 |
Diabetes | 261, 413 |
Diabetes mellitus | 169 |
Diltiazem hydrochloride | 340 |
Dissolution | 82, 310 |
Dissolution rate | 48 |
DNA | 175 |
Docking | 196 |
Docking studies | 392 |
Drug delivery | 493 |
Drug release | 437 |
Drug–drug interactions | 14 |
Dual biofilm | 356 |
E. faecalis | 356 |
Edible mushroom | 76 |
Emission wavelength-286 nm | 82 |
Entrapment efficiency | 437 |
Epidermal thickness | 292 |
Erectile function | 317 |
Ergosterol | 37 |
Essential oil | 220 |
ESX | 196 |
Etoposide | 132 |
Eudragit EPO | 132 |
Eudragit RL and RS | 340 |
Ex vivo study | 348 |
Excitation wavelength-263 nm | 82 |
Extended release | 340 |
Fatty acid | 220 |
Fenofibrate | 48 |
Ferric chloride | 422 |
Ferula | 69 |
Ferula tenuissima | 488 |
Ferulago | 69, 317 |
FISH | 96 |
Fibroblast | 169 |
Ficus carica | 413 |
Ficus species | 375 |
Flavonoid glycosides | 191 |
Flavonoids | 234 |
Floating multiparticulate | 326 |
Flunarizine | 303 |
Fluorescence analysis | 76 |
Forced degradation | 82, 404 |
FTIR | 43 |
Galantamine | 32 |
Gamma irradiation | 43 |
Gastroretentive | 326 |
Gelatin | 20 |
Gelatinase | 356 |
Gemifloxacin Mesylate | 8 |
Genotoxicity | 282 |
Gibbs free energy | 48 |
Glassy carbon electrode | 184, 462 |
Glipizide | 265 |
Glutathione-S-transferase | 155 |
Grant | 115 |
Growth inhibition | 387 |
Gypsophila laricina | 220 |
H index | 115 |
Haematinic activity | 27 |
Heat-not-burn tobacco products | 371 |
Hematology | 88 |
Hemeoxygenase-1 | 54 |
Hepatoprotective activity | 428 |
Heracleum | 191 |
Hippomarathrum | 69 |
Histone deacetylase inhibitors | 101 |
Histopathology | 88 |
HPLC | 32, 404, 469 |
Human plasma | 227 |
Human red blood cell membrane | 240 |
Human umbilical vein endothelial cells | 303 |
Hydrazinecarbothioamide | 1 |
Hydrazone | 444 |
Hydrocortisone | 348 |
Hydroxy propyl β-cyclodextrin | 48 |
Hypoglycemic activity | 261 |
Imidazo[2,1-b]thiazole | 1 |
Immobilization | 206 |
Impact factor | 115 |
Impurity A | 469 |
Impurity B | 469 |
In vitro anti-inflammatory activity | 392 |
In vivo hypoglycemic activity | 392 |
Inflammation | 54, 362 |
Interleukin-1β | 362 |
Internal transcribed spacer | 76 |
Ionizing radiation | 366 |
IQOS® | 371 |
Isocratic | 227 |
Isolation | 206 |
Isorhamnetin | 191 |
Itraconazole | 211 |
L-arginine | 20 |
Lathyrus | 240 |
Leflunomide | 469 |
Linagliptin | 227 |
Lipinski’s rule of five | 141 |
Lornoxicam | 422 |
Lupeol | 449 |
Malaria | 37 |
Mannich reaction | 392 |
MAO-A and B | 449 |
MCF-7 | 387 |
MCR co-processing | 161 |
MCR tableting properties | 161 |
Medicinal plants | 246 |
Mesalamine | 422 |
Meso-2,3-dimercaptosuccinic acid coated silver sulfide quantum dots | 282 |
Methanol extract | 335 |
Method validation | 8 |
Methyldopa | 462 |
Microcrystalline cellulose | 161 |
Microglia | 54 |
Micronization | 335 |
Microspheres | 20, 340 |
Molecular docking | 119 |
Moraceae | 375 |
Moringa peregrina | 362 |
Multidrug resistant | 196 |
Multiple sclerosis | 246 |
Multitherapeutic approach | 101 |
Multiwalled carbon nanotubes | 184 |
Mycobacterium tuberculosis | 196 |
Nanocarrier | 493 |
Nanomaterials | 493 |
Nanoparticles | 43, 132, 265 |
NCI-H460 | 387 |
Neurodegenerative | 449 |
Nicotine | 371 |
Nitric oxide | 362 |
Norfloxacin | 326 |
Nutraceuticals | 37 |
Olopatadine hydrochloride | 404 |
Oral films | 348 |
Oxidative stress | 428 |
Palmitic acid | 265 |
Particle size | 437 |
pH | 252 |
Pharmaceutical cocrystal | 310 |
Pharmacist | 14 |
Phenolic compounds | 375 |
Phenylhydrazine | 27 |
Phlebodium decumanum | 292 |
Phytochemical screening | 478 |
Phytochemicals | 76 |
Phytotherapy | 246 |
Piperine | 366 |
Pleurotus ostreatus | 37 |
Pluronic F-68 | 132 |
Pluronics | 265 |
Pocket modeling | 196 |
Poly (p-aminobenzene sulfonic acid) | 462 |
Polyphenolic compounds | 155 |
Polyphenols | 234 |
Praziquantel | 82 |
Prostate cancer | 488 |
Protein kinase C | 169 |
Pseudomonas aeruginosa | 456 |
PSI | 292 |
Psoriasis | 292 |
PVA | 252 |
Quantitative reverse transcription polymerase chain reaction | 356 |
Quantitative structure–activity relationship | 141 |
Quercetin | 54 |
Radioprotective genotoxicity | 366 |
Rat aortic ring assay | 303 |
Regenerated cellulose | 161 |
Rosa damascena | 428 |
Rosemary | 43 |
S. aureus | 356 |
Sacrificial excipients | 211 |
Salicylaldehyde reagent | 422 |
Sargassum wightii | 478 |
Saxagliptin | 227 |
Scientific performance | 115 |
Sec | 196 |
Semen boron concentration | 96 |
Sepsis | 428 |
Smoking | 371 |
Sodium alginate | 252 |
Software programs | 14 |
Solid dispersion | 211 |
Solid lipid nanoparticles | 437 |
Solubility | 48, 310, 335 |
Solvent casting method | 348 |
Spheronization | 326 |
Sponge implantation method | 303 |
Sternbergia spp. | 32 |
Stress degradation | 469 |
Subchronic toxicity | 88, 478 |
Swelling | 252 |
Tamarindus indica | 27 |
Targeting | 493 |
Tenoxicam | 184 |
Tensile strength | 348 |
Tenure | 115 |
Thiadiazole | 119 |
Thiazolidinediones bearing morpholine | 392 |
Transmission electron microscopy | 43 |
Ultra performance liquid chromatography | 8 |
Underutilized vegetable | 449 |
Vaccinium arctostaphylos | 175 |
Vinca rosea | 335 |
Visible spectrophotometry | 422 |
Vitex grandifolia | 449 |
Voltammetry | 184, 462 |
West Bengal | 76 |
Wild mushrooms | 155 |
X-ray diffraction | 43 |
Y:X sperm ratio | 96 |
Yield percentages | 375 |
Zaltoprofen | 310 |
Zeta potential | 437 |